Jean‐François Eliaou

Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus

Agnès Doreau, Alexandre Belot, Jérémy Bastid et al. · Nature Immunology · 2009 · 446 citations

Immune Regulation, Immunology, Immune Dysregulation +17

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

Ivan Perrot, Henri‐Alexandre Michaud, Marc Giraudon-Paoli et al. · Cell Reports · 2019 · 404 citations · Full text

Cancer Immunosurveillance, Medicine, Immune Checkpoint Inhibitors +15

Prognostic factors for radiographic damage in early rheumatoid arthritis: A multiparameter prospective study

Bernard Combe, Maxime Dougados, Philippe Goupille et al. · Arthritis & Rheumatism · 2001 · 283 citations

Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

Jérémy Bastid, Anne Regairaz, Nathalie Bonnefoy et al. · Cancer Immunology Research · 2014 · 237 citations

Cd39 Enzymatic Function, T-regulatory Cell, Immunology +25

CD4⁺T Cell Surface CCR5 Density as a Determining Factor of Virus Load in Persons Infected with Human Immunodeficiency Virus Type 1

Jacques Reynes, Pierre Portalès, Michel Segondy et al. · The Journal of Infectious Diseases · 2000 · 175 citations · Full text

Immunodeficiencies, Immunology, Pathology +21